Carnitine deficiency provokes cisplatin-induced hepatotoxicity in rats

被引:49
作者
Al-Majed, Abdulhakeem A. [1 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmacol, Riyadh 11451, Saudi Arabia
关键词
PERFORMANCE LIQUID-CHROMATOGRAPHY; PROPIONYL-L-CARNITINE; ACETYL-L-CARNITINE; PROCAINAMIDE HYDROCHLORIDE; INDUCED NEPHROTOXICITY; NITRIC-OXIDE; TISSUE; DAMAGE; LIVER; CHEMOTHERAPY;
D O I
10.1111/j.1742-7843.2006.00024.x
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
This study investigates whether or not carnitine deficiency is a risk factor and could contribute to cisplatin-induced liver toxicity. A total of 60 adult male Wistar albino rats were divided into six groups. The first three groups were injected intraperitoneally with normal saline, propionyl-L-carnitine (500 mg/kg), and D-carnitine (500 mg/kg), respectively, for 10 successive days. The fourth, fifth and sixth groups were injected intraperitoneally with the same doses of normal saline, propionyl-L-carnitine and D-carnitine, respectively, for 5 successive days before and after a single dose of cisplatin (7 mg/kg). Administration of the standard nephrotoxic dose of cisplatin did not produce any changes in serum alanine transaminase and gamma-glutamyl transferase and no morphological changes in liver tissues. However, it did produce a significant increase in thiobarbituric acid reactive substances and total nitrate/nitrite and a significant decrease in reduced glutathione content in liver tissues. On the other hand, combined treatment with cisplatin and D-carnitine induced a dramatic increase in serum alanine transaminase and gamma-glutamyl transferase, as well as progressive reduction in total carnitine and ATP content in liver tissue. Moreover, histopathological examination of liver tissues confirmed the biochemical data, where cisplatin and D-carnitine combination showed signs of liver injury manifested as focal necro-inflammatory changes and portal inflammation. Interestingly, in carnitine supplemented rats using propionyl-L-carnitine, cisplatin did not produce any biochemical and histopathological changes in liver tissues. In conclusion, data from this study suggest for the first time that (1) carnitine deficiency is a risk factor and could precipitate cisplatin-induced hepatotoxicity, (2) oxidative stress is not the main cause of cisplatin-related hepatotoxicity and (3) propionyl-L-carnitine prevents the development of cisplatin-induced liver injury.
引用
收藏
页码:145 / 150
页数:6
相关论文
共 36 条
[1]
Effect of spironolactone on cisplatin-induced nephrotoxicity in rabbits [J].
Ahmida, MHS ;
Abdel-Gayoum, AA ;
El-Fakhri, MM .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2001, 20 (09) :453-459
[2]
Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model [J].
Al-Majed, AA ;
Sayed-Ahmed, MM ;
Al-Yahya, AA ;
Aleisa, AM ;
Al-Rejaie, SS ;
Al-Shabanah, OA .
PHARMACOLOGICAL RESEARCH, 2006, 53 (03) :278-286
[4]
Protective role of carnitine esters against alcohol-induced gastric lesions in rats [J].
Arafa, HMM ;
Sayed-Ahmed, MM .
PHARMACOLOGICAL RESEARCH, 2003, 48 (03) :285-290
[5]
ACUTE CORONARY EVENTS FOLLOWING CISPLATIN-BASED CHEMOTHERAPY [J].
BERLINER, S ;
RAHIMA, M ;
SIDI, Y ;
TEPLITSKY, Y ;
ZOHAR, Y ;
NUSSBAUM, B ;
PINKHAS, J .
CANCER INVESTIGATION, 1990, 8 (06) :583-586
[6]
ANALYTICAL EVALUATION OF HIGH-ENERGY PHOSPHATE DETERMINATION BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY IN MYOCARDIAL TISSUE [J].
BOTKER, HE ;
KIMOSE, HH ;
HELLIGSO, P ;
NIELSEN, TT .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1994, 26 (01) :41-48
[7]
HEPATOTOXICITY ASSOCIATED WITH CISPLATIN CHEMOTHERAPY [J].
CERSOSIMO, RJ .
ANNALS OF PHARMACOTHERAPY, 1993, 27 (04) :438-441
[8]
TISSUE SULFHYDRYL GROUPS [J].
ELLMAN, GL .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1959, 82 (01) :70-77
[9]
Fenoglio C, 2005, ANTICANCER RES, V25, P4123